224 related articles for article (PubMed ID: 21752290)
1. Alendronate (ALN) combined with osteoprotegerin (OPG) significantly improves mechanical properties of long bone than the single use of ALN or OPG in the ovariectomized rats.
Wang Y; Huang P; Tang PF; Chan KM; Li G
J Orthop Surg Res; 2011 Jul; 6():34. PubMed ID: 21752290
[TBL] [Abstract][Full Text] [Related]
2. Once-weekly parathyroid hormone combined with ongoing long-term alendronate treatment promotes osteoporotic fracture healing in ovariectomized rats.
Zhang C; Zhu J; Jia J; Guan Z; Sun T; Zhang W; Yuan W; Wang H; Leng H; Song C
J Orthop Res; 2021 Oct; 39(10):2103-2115. PubMed ID: 33325546
[TBL] [Abstract][Full Text] [Related]
3. Alendronate retards the progression of lumbar intervertebral disc degeneration in ovariectomized rats.
Luo Y; Zhang L; Wang WY; Hu QF; Song HP; Su YL; Zhang YZ
Bone; 2013 Aug; 55(2):439-48. PubMed ID: 23500174
[TBL] [Abstract][Full Text] [Related]
4. Bovine lactoferrin improves bone mass and microstructure in ovariectomized rats via OPG/RANKL/RANK pathway.
Hou JM; Xue Y; Lin QM
Acta Pharmacol Sin; 2012 Oct; 33(10):1277-84. PubMed ID: 22902986
[TBL] [Abstract][Full Text] [Related]
5. Effects of combined treatment with eldecalcitol and alendronate on bone mass, mechanical properties, and bone histomorphometry in ovariectomized rats: a comparison with alfacalcidol and alendronate.
Sugimoto M; Futaki N; Harada M; Kaku S
Bone; 2013 Jan; 52(1):181-8. PubMed ID: 23041510
[TBL] [Abstract][Full Text] [Related]
6. Anti-RANKL treatment improves screw fixation in cancellous bone in rats.
Bernhardsson M; Sandberg O; Aspenberg P
Injury; 2015; 46(6):990-5. PubMed ID: 25744169
[TBL] [Abstract][Full Text] [Related]
7. Effects of denosumab, alendronate, or denosumab following alendronate on bone turnover, calcium homeostasis, bone mass and bone strength in ovariectomized cynomolgus monkeys.
Kostenuik PJ; Smith SY; Samadfam R; Jolette J; Zhou L; Ominsky MS
J Bone Miner Res; 2015 Apr; 30(4):657-69. PubMed ID: 25369992
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D, osteoprotegerin/receptor activator of nuclear factor-kappaB ligand (OPG/RANKL) and inflammation with alendronate treatment in HIV-infected patients with reduced bone mineral density.
Natsag J; Kendall MA; Sellmeyer DE; McComsey GA; Brown TT
HIV Med; 2016 Mar; 17(3):196-205. PubMed ID: 26177791
[TBL] [Abstract][Full Text] [Related]
9. Comparable effects of alendronate and strontium ranelate on femur in ovariectomized rats.
Chen B; Li Y; Yang X; Xie D
Calcif Tissue Int; 2013 Nov; 93(5):481-6. PubMed ID: 23897224
[TBL] [Abstract][Full Text] [Related]
10. Salidroside Improves Bone Histomorphology and Prevents Bone Loss in Ovariectomized Diabetic Rats by Upregulating the OPG/RANKL Ratio.
Zheng H; Qi S; Chen C
Molecules; 2018 Sep; 23(9):. PubMed ID: 30235836
[TBL] [Abstract][Full Text] [Related]
11. Increased bone formation and bone mass induced by sclerostin antibody is not affected by pretreatment or cotreatment with alendronate in osteopenic, ovariectomized rats.
Li X; Ominsky MS; Warmington KS; Niu QT; Asuncion FJ; Barrero M; Dwyer D; Grisanti M; Stolina M; Kostenuik PJ; Simonet WS; Paszty C; Ke HZ
Endocrinology; 2011 Sep; 152(9):3312-22. PubMed ID: 21733832
[TBL] [Abstract][Full Text] [Related]
12. Comparison of calcitonin, alendronate and fluorophosphate effects on ovariectomized rat bone.
Giavaresi G; Fini M; Gnudi S; Aldini NN; Rocca M; Carpi A; Giardino R
Biomed Pharmacother; 2001 Sep; 55(7):397-403. PubMed ID: 11669503
[TBL] [Abstract][Full Text] [Related]
13. RANKL inhibition with osteoprotegerin increases bone strength by improving cortical and trabecular bone architecture in ovariectomized rats.
Ominsky MS; Li X; Asuncion FJ; Barrero M; Warmington KS; Dwyer D; Stolina M; Geng Z; Grisanti M; Tan HL; Corbin T; McCabe J; Simonet WS; Ke HZ; Kostenuik PJ
J Bone Miner Res; 2008 May; 23(5):672-82. PubMed ID: 18433301
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of alendronate and alfacalcidol on cancellous and cortical bone mass and bone mechanical properties in ovariectomized rats.
Iwamoto J; Seki A; Takeda T; Sato Y; Yamada H; Yeh JK
Exp Anim; 2006 Jul; 55(4):357-67. PubMed ID: 16880683
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy with eldecalcitol and alendronate has therapeutic advantages over monotherapy by improving bone strength.
Sakai S; Endo K; Takeda S; Mihara M; Shiraishi A
Bone; 2012 May; 50(5):1054-63. PubMed ID: 22366400
[TBL] [Abstract][Full Text] [Related]
16. Effects of combined elcatonin and alendronate treatment on the architecture and strength of bone in ovariectomized rats.
Ogawa K; Hori M; Takao R; Sakurada T
J Bone Miner Metab; 2005; 23(5):351-8. PubMed ID: 16133684
[TBL] [Abstract][Full Text] [Related]
17. Effect of alendronate on the femoral metaphyseal defect under carbamazepine in ovariectomized rats.
Zhang R; Yang M; Li Y; Liu H; Ren M; Tao ZS
J Orthop Surg Res; 2021 Jan; 16(1):14. PubMed ID: 33407695
[TBL] [Abstract][Full Text] [Related]
18. Increased RANK ligand in bone marrow of orchiectomized rats and prevention of their bone loss by the RANK ligand inhibitor osteoprotegerin.
Li X; Ominsky MS; Stolina M; Warmington KS; Geng Z; Niu QT; Asuncion FJ; Tan HL; Grisanti M; Dwyer D; Adamu S; Ke HZ; Simonet WS; Kostenuik PJ
Bone; 2009 Oct; 45(4):669-76. PubMed ID: 19539794
[TBL] [Abstract][Full Text] [Related]
19. Alendronate inhibits osteocyte apoptosis and inflammation via IL-6, inhibiting bone resorption in periapical lesions of ovariectomized rats.
Silva RAB; Sousa-Pereira AP; Lucisano MP; Romualdo PC; Paula-Silva FWG; Consolaro A; Silva LAB; Nelson-Filho P
Int Endod J; 2020 Jan; 53(1):84-96. PubMed ID: 31429089
[TBL] [Abstract][Full Text] [Related]
20. Osteoprotegerin is an effective countermeasure for spaceflight-induced bone loss in mice.
Lloyd SA; Morony SE; Ferguson VL; Simske SJ; Stodieck LS; Warmington KS; Livingston EW; Lacey DL; Kostenuik PJ; Bateman TA
Bone; 2015 Dec; 81():562-572. PubMed ID: 26318907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
